MarketWatch PURA News - Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses
March 01 2017 - 1:47PM
InvestorsHub NewsWire
Originally Published By
MarketWatch
PALM BEACH, Florida, Feb 28, 2017
The accelerating consumer acceptance and expanding legalization of
legal marijuana as well as cannabis infused products and its
medicinal applications has resulted in many new opportunities for
cannabis based companies and operators. Consumers can now obtain
the benefits of legal marijuana without have to smoke the substance
as popularity grows for CBD infused products from skin care to
medicinal therapies to infused consumer goods and water products.
Cannabis, medicinal marijuana, CBD infused product companies
include: Puration, Inc. , OWC Pharmaceutical Research Corp. ,
Cannabis Science, Inc. , Medical Marijuana, Inc. and GrowBlox
Sciences, Inc. .
Puration, Inc. and Alkame Holdings, Inc. (ALKM)
today announced that the two Companies will partner to introduce a
second EVERx Bottled Water product at the upcoming Annual Arnold
Sports Festival (formerly the 'Arnold Classic' named for Arnold
Schwarzenegger) in Columbus, Ohio this week, starting March 2nd,
2017. PURA previously announced the launch of its EVERx CBD Infused
Bottled Water to take place at the Arnold. Today, the two companies
are announcing that PURA will private label ALKM's patented
Alkaline Water under the EVERx brand name. Both EVERx CBD Infused
Bottled Water and EVERx Alkaline Bottled Water will be launched at
the Arnold. Title contender, number three ranked UFC MMA women's
bantamweight fighter, Julianna Pena will be the EVERx Brand
Spokesperson at the Arnold for both EVERx CBD Infused Bottled Water
and EVERx Alkaline Water. Read this and more news for PURA
at: http://marketnewsupdates.com/news/pura.html
To learn more about the EVERx Brand Product Launch at the Arnold
Sports Festival, follow this link EVERx BRAND LAUNCH AT THE ARNOLD
SPORTS FESTIVAL [https://www.drinkeverx.com ]
ALKM's patented technology
alters the structure of water, producing a combination of
characteristics that are unprecedented in the beverage industry.
The ALKM technology breaks down the hydrogen bonds, reducing
water's cluster size, providing a more efficient delivery system
for the CBD in the EVERx CBD Infused Bottled Water, and the ALKM
technology includes an optimal alkaline pH level formulated with
antioxidants and electrolytes so that the EVERx Alkaline Bottled
water can deliver most effective hydration available in the
alkaline water market.
In other cannabis
developments of note:
OWC Pharmaceutical Research Corp. (OTCQB:OWCP),
an Israeli-based developer of cannabinoid-based therapies targeting
a variety of different medical conditions and disorders, yesterday
announced it has received Institutional Review Board (IRB) approval
to conduct safety testing on its proprietary topical creme compound
for the treatment of psoriasis and related skin conditions. The
approval follows the Company's February 1, 2017 8K filing
announcing an extension to the size and scope of its efficacy study
on the same compound, which began in November 2106.
Cannabis Science, Inc. , a U.S. company specializing in the
development of cannabis-based medicines, announced late last week
updates on the proposed self-medicating DPI Inhalation Device for
Asthma/COPD and our Cannabinoid infused pain patch. The Company is
working on the final packaging for the Cannabinoid-based Pain
Patches and will roll out to partner dispensaries in the Los
Angeles area very soon, joining the existing Cannabis Science
product line.
Medical Marijuana, Inc. , the first publicly traded cannabis
company in the United States, subsidiary, HempMeds(R) Brasil
announced last week that the Brazilian government has authorized a
doctor's prescription for the Company's hemp cannabidiol (CBD) oil
product Real Scientific Hemp Oil(TM) (RSHO(TM)) to treat patients
in the country suffering from Multiple Sclerosis. This marks the
first time that Brazil's National Health Surveillance Agency ANVISA
has granted the filling of a prescription for RSHO(TM) to
specifically help patients combat the effects of Multiple
Sclerosis. Per the Multiple Sclerosis International Federation
(MSIF), more than 2.5million people worldwide are affected by MS, a
progressive disease of the central nervous system, for which there
is currently no cure. In Brazil, MS prevalence is estimated to
range from 1.36-20 per 100,000 inhabitants.
GrowBlox Sciences, Inc. (OTCQB:GBLX)
announced earlier this month, filing the second in a series of
patent applications for life science inventions by its wholly-owned
subsidiary, Growblox Life Sciences, LLC. Inflammatory disorders
represent a serious health and economic burden in the US with over
$200 billion spent annually. GB Sciences' novel cannabis-based
therapies could significantly help both patients and society.
According to the CDC, arthritis affects 22.7% (52.5 million) of
adults in the US (2010-2012), and the prevalence is projected to
increase to an estimated 26% (78 million of the projected total
adult population) by 2040.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher
and news dissemination service provider, which disseminates
electronic information through multiple online media channels. MNU
is NOT affiliated in any manner with any company mentioned herein.
MNU and its affiliated companies are a news dissemination solutions
provider and are NOT a registered broker/dealer/analyst/adviser,
holds no investment licenses and may NOT sell, offer to sell or
offer to buy any security. MNU's market updates, news alerts and
corporate profiles are NOT a solicitation or recommendation to buy,
sell or hold securities. The material in this release is intended
to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to
perform research and due diligence on their own and consult a
licensed financial professional before considering any level of
investing in stocks. All material included herein is republished
content and details which were previously disseminated by the
companies mentioned in this release. MNU is not liable for any
investment decisions by its readers or subscribers. Investors are
cautioned that they may lose all or a portion of their investment
when investing in stocks. For current services performed MNU has
been compensated three thousand nine hundred dollars for news
coverage of the current press release issued by Puration, Inc. by a
non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY
NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or "planned", "will" or "should",
"expected," "anticipates", "draft", "eventually" or "projected".
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and MNU undertakes no
obligation to update such statements.
Contact Information: Media Contact email:
info@marketnewsupdates.com Tel:(561)-325-8757
Copyright (C) 2017 PR Newswire Europe
Republished By Wall Street Corner Report
Wall Street Corner Report is the premier discovery site for
promising, yet undiscovered small and micro-cap stocks featuring
opportunities in an ethical, professional, and responsible manner.
We're not fiendishly 'short' sighted nor are we here to dream the
impossibly 'long' dream. We take a practical view on the big
ideas of well-intentioned management and look to profit on each
reasonably achievable step the well intentioned mangers take toward
their big ideas.
http://www.wallstreetcornerreport.com/more-news/
https://twitter.com/WallStCornerRpt
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and as such, may involve risks and
uncertainties. These forward looking statements relate to, amongst
other things, current expectation of the business environment in
which the company operates, potential future performance,
projections of future performance and the perceived opportunities
in the market. The company's actual performance, results and
achievements may differ materially from the expressed or implied in
such forward-looking statements as a result of a wide range of
factors.
Jack Taylor
info@wallstreetcornerreport.com